J. Allinson

发表

Exodus or renaissance?: Metropolitan migration in the late 1990s

J. Allinson, 2005 .

Analytical techniques for multiplex analysis of protein biomarkers

K. Kyriacou, J. Vacek, T. Luider, 2020, Expert review of proteomics.

Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development

Masood U Khan, V. Devanarayan, A. Jeromin, 2015, The AAPS Journal.

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, B

Yow-Ming C Wang, Andrew P Mayer, M. Fiscella, 2019, Bioanalysis.

Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report

Lauren F Stevenson, Yow-Ming C Wang, V. Devanarayan, 2022, AAPS Open.

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

Viswanath Devanarayan, Russell Weiner, Chad Ray, 2006, Pharmaceutical Research.

Feedback from the EBF - Focus Workshop: bringing assay validation and analysis of biomarkers into practice.

P. Timmerman, B. Barroso, Ulrich Kunz, 2017, Bioanalysis.

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).

Sam H Haidar, Gustavo Mendes Lima Santos, Sam H. Haidar, 2016, Bioanalysis.

White Pa P er SP ecial Focu S iSS ue: Bioanaly S i S o F B iomarker S

Rafiq Islam, R. Lelacheur, S. Reuschel, 2012 .

The 4.4 Million Households: Do We Really Need Them Anyway?

J. Allinson, 1999 .

Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development

V. Devanarayan, A. Jeromin, J. Allinson, 2015, The AAPS Journal.

Recommendations on biomarker bioanalytical method validation by GCC.

Roger Hayes, Fabio Garofolo, John Allinson, 2012, Bioanalysis.

Considerations for Soluble Protein Biomarker Blood Sample Matrix Selection

J. Allinson, C. Ray, M. Hokom, 2020, The AAPS Journal.

Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).

Roger Hayes, Jennifer Zimmer, Xinping Fang, 2012, Bioanalysis.

Recommendations on incurred sample stability (ISS) by GCC.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2014, Bioanalysis.

The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2017, Bioanalysis.

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity).

Renuka Pillutla, Viswanath Devanarayan, An Song, 2015, Bioanalysis.